Rank | Gene Set | Z-score |
---|---|---|
1 | neutrophil activation involved in immune response (GO:0002283) | 6.46463009 |
2 | immunoglobulin mediated immune response (GO:0016064) | 5.96619148 |
3 | response to peptidoglycan (GO:0032494) | 5.49873331 |
4 | positive regulation of mast cell activation (GO:0033005) | 5.20954862 |
5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.10334570 |
6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.10334570 |
7 | modulation by symbiont of host immune response (GO:0052553) | 5.10334570 |
8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.10334570 |
9 | modulation by symbiont of host defense response (GO:0052031) | 5.10334570 |
10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.10334570 |
11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.10119014 |
12 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 5.05216429 |
13 | positive regulation of mast cell degranulation (GO:0043306) | 5.05216429 |
14 | detection of molecule of bacterial origin (GO:0032490) | 4.95652796 |
15 | macrophage activation involved in immune response (GO:0002281) | 4.81712272 |
16 | detection of other organism (GO:0098543) | 4.73620334 |
17 | negative regulation of interleukin-12 production (GO:0032695) | 4.69028192 |
18 | B cell mediated immunity (GO:0019724) | 4.68649124 |
19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.61184184 |
20 | cellular extravasation (GO:0045123) | 4.49806192 |
21 | detection of external biotic stimulus (GO:0098581) | 4.49448962 |
22 | detection of bacterium (GO:0016045) | 4.48387104 |
23 | neutrophil activation (GO:0042119) | 4.43025139 |
24 | regulation of mast cell degranulation (GO:0043304) | 4.39053438 |
25 | negative regulation of cell killing (GO:0031342) | 4.31484081 |
26 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.31484081 |
27 | microglial cell activation (GO:0001774) | 4.30118118 |
28 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.28458159 |
29 | regulation of mast cell activation (GO:0033003) | 4.28365812 |
30 | granulocyte activation (GO:0036230) | 4.24265029 |
31 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.22469677 |
32 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.21224784 |
33 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 4.17556837 |
34 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.08990260 |
35 | myeloid cell activation involved in immune response (GO:0002275) | 4.06217280 |
36 | regulation of hypersensitivity (GO:0002883) | 4.04951674 |
37 | detection of biotic stimulus (GO:0009595) | 3.98654170 |
38 | positive regulation of leukocyte degranulation (GO:0043302) | 3.84100241 |
39 | macrophage activation (GO:0042116) | 3.80525379 |
40 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.77310821 |
41 | respiratory burst (GO:0045730) | 3.76683934 |
42 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.72097435 |
43 | regulation of gamma-delta T cell activation (GO:0046643) | 3.57905577 |
44 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.57588930 |
45 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.56967882 |
46 | positive regulation of type 2 immune response (GO:0002830) | 3.56128307 |
47 | regulation of leukocyte degranulation (GO:0043300) | 3.56038269 |
48 | response to host immune response (GO:0052572) | 3.54877077 |
49 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.54877077 |
50 | T-helper 1 type immune response (GO:0042088) | 3.49843320 |
51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.49237830 |
52 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.42420508 |
53 | regulation of T cell tolerance induction (GO:0002664) | 3.40759410 |
54 | positive regulation of antigen processing and presentation (GO:0002579) | 3.40515451 |
55 | regulation of tolerance induction (GO:0002643) | 3.37481542 |
56 | cellular response to interferon-gamma (GO:0071346) | 3.33209357 |
57 | regulation of antigen processing and presentation (GO:0002577) | 3.32421906 |
58 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.31773243 |
59 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.28316911 |
60 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.23062502 |
61 | neutrophil mediated immunity (GO:0002446) | 3.23002554 |
62 | leukocyte aggregation (GO:0070486) | 3.19035944 |
63 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.16418174 |
64 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.15941813 |
65 | defense response to protozoan (GO:0042832) | 3.15488154 |
66 | myeloid leukocyte activation (GO:0002274) | 3.13465129 |
67 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.12939161 |
68 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.12453644 |
69 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.11884845 |
70 | response to host (GO:0075136) | 3.11884845 |
71 | response to host defenses (GO:0052200) | 3.11884845 |
72 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.10477262 |
73 | mast cell activation (GO:0045576) | 3.10174826 |
74 | response to interferon-gamma (GO:0034341) | 3.09947073 |
75 | response to muramyl dipeptide (GO:0032495) | 3.08784938 |
76 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.08421764 |
77 | neutrophil chemotaxis (GO:0030593) | 3.08333190 |
78 | positive regulation of regulated secretory pathway (GO:1903307) | 3.06882688 |
79 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.06855664 |
80 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.06807470 |
81 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.05635412 |
82 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.05022149 |
83 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.03149009 |
84 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.01559186 |
85 | neutrophil migration (GO:1990266) | 3.00797036 |
86 | negative regulation of T cell mediated immunity (GO:0002710) | 2.99784632 |
87 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.98911113 |
88 | regulation of regulated secretory pathway (GO:1903305) | 2.97984035 |
89 | leukocyte degranulation (GO:0043299) | 2.96303122 |
90 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.95324153 |
91 | type I interferon signaling pathway (GO:0060337) | 2.95263076 |
92 | cellular response to type I interferon (GO:0071357) | 2.95263076 |
93 | regulation of type 2 immune response (GO:0002828) | 2.92809901 |
94 | response to protozoan (GO:0001562) | 2.91591222 |
95 | positive regulation of B cell differentiation (GO:0045579) | 2.90522798 |
96 | response to type I interferon (GO:0034340) | 2.89956808 |
97 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.89631302 |
98 | myeloid dendritic cell activation (GO:0001773) | 2.88956660 |
99 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.88897121 |
100 | granulocyte chemotaxis (GO:0071621) | 2.87578981 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.46216147 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.35243431 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.44057054 |
4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.05665791 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.71174810 |
6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.59495067 |
7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.52725610 |
8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.35220977 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.28868808 |
10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.18939183 |
11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.02571564 |
12 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.99131746 |
13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.91122479 |
14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.87180046 |
15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.81257420 |
16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.71722974 |
17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.68823557 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.60823441 |
19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.59175655 |
20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.55940398 |
21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.35140040 |
22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.27164290 |
23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.27067433 |
24 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.26178546 |
25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20906988 |
26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.19607733 |
27 | MYB_26560356_Chip-Seq_TH2_Human | 2.09112050 |
28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.98631315 |
29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.98175286 |
30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88899741 |
31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.79737168 |
32 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73956645 |
33 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.69190461 |
34 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67302344 |
35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67118050 |
36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.62322617 |
37 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.61998103 |
38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.60713166 |
39 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.59954881 |
40 | MYB_26560356_Chip-Seq_TH1_Human | 1.58416350 |
41 | MAF_26560356_Chip-Seq_TH1_Human | 1.57425608 |
42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56583160 |
43 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.56153991 |
44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.54570017 |
45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51549789 |
46 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51027584 |
47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.49069655 |
48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.42974160 |
49 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39800286 |
50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.33728114 |
51 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.32775728 |
52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29432310 |
53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27760752 |
54 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.27026339 |
55 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26268885 |
56 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24665809 |
57 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23929501 |
58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19586894 |
59 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17562626 |
60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13344799 |
61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12051686 |
62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10355051 |
63 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07049279 |
64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06964474 |
65 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05799947 |
66 | MAF_26560356_Chip-Seq_TH2_Human | 1.02486553 |
67 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00359820 |
68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98409256 |
69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97958487 |
70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97469257 |
71 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.97161482 |
72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95941258 |
73 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93196722 |
74 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92973872 |
75 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91592774 |
76 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.89029823 |
77 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.88880065 |
78 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87241624 |
79 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.86210782 |
80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83305486 |
81 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.82823088 |
82 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.82681299 |
83 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76989220 |
84 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.76917117 |
85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.76831143 |
86 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.75574171 |
87 | MYC_22102868_ChIP-Seq_BL_Human | 0.71079163 |
88 | GATA1_19941826_ChIP-Seq_K562_Human | 0.70559290 |
89 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.69843736 |
90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69709316 |
91 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.68900321 |
92 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.68310594 |
93 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67829588 |
94 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.65627196 |
95 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.65310582 |
96 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.64747501 |
97 | GATA3_26560356_Chip-Seq_TH1_Human | 0.64624274 |
98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.63589549 |
99 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.63565454 |
100 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61985528 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.60088908 |
2 | MP0003724_increased_susceptibility_to | 4.39399489 |
3 | MP0003436_decreased_susceptibility_to | 3.75377292 |
4 | MP0005671_abnormal_response_to | 3.65481655 |
5 | MP0003303_peritoneal_inflammation | 3.44641536 |
6 | MP0009785_altered_susceptibility_to | 3.38636625 |
7 | MP0006082_CNS_inflammation | 3.30738177 |
8 | MP0002419_abnormal_innate_immunity | 3.27390835 |
9 | MP0002148_abnormal_hypersensitivity_rea | 3.13252610 |
10 | MP0005000_abnormal_immune_tolerance | 2.93989898 |
11 | MP0005025_abnormal_response_to | 2.89800232 |
12 | MP0001800_abnormal_humoral_immune | 2.81350638 |
13 | MP0005387_immune_system_phenotype | 2.70119122 |
14 | MP0001790_abnormal_immune_system | 2.70119122 |
15 | MP0002452_abnormal_antigen_presenting | 2.64247233 |
16 | MP0002723_abnormal_immune_serum | 2.57684687 |
17 | MP0000685_abnormal_immune_system | 2.41668473 |
18 | MP0002420_abnormal_adaptive_immunity | 2.33613217 |
19 | MP0001819_abnormal_immune_cell | 2.32807613 |
20 | MP0009764_decreased_sensitivity_to | 2.27693563 |
21 | MP0003172_abnormal_lysosome_physiology | 2.17615356 |
22 | MP0001533_abnormal_skeleton_physiology | 2.11248713 |
23 | MP0005058_abnormal_lysosome_morphology | 2.11198758 |
24 | MP0003191_abnormal_cellular_cholesterol | 2.09297830 |
25 | MP0003300_gastrointestinal_ulcer | 2.08894897 |
26 | MP0005464_abnormal_platelet_physiology | 2.08301187 |
27 | MP0003075_altered_response_to | 2.04855874 |
28 | MP0001845_abnormal_inflammatory_respons | 1.86895614 |
29 | MP0002405_respiratory_system_inflammati | 1.80368203 |
30 | MP0003828_pulmonary_edema | 1.72452058 |
31 | MP0010155_abnormal_intestine_physiology | 1.71364364 |
32 | MP0000343_altered_response_to | 1.67219961 |
33 | MP0000716_abnormal_immune_system | 1.67129282 |
34 | MP0008469_abnormal_protein_level | 1.64821816 |
35 | MP0001853_heart_inflammation | 1.64249380 |
36 | MP0008260_abnormal_autophagy | 1.59685945 |
37 | MP0003806_abnormal_nucleotide_metabolis | 1.59268118 |
38 | MP0000569_abnormal_digit_pigmentation | 1.59050879 |
39 | MP0005397_hematopoietic_system_phenotyp | 1.54531280 |
40 | MP0001545_abnormal_hematopoietic_system | 1.54531280 |
41 | MP0002398_abnormal_bone_marrow | 1.54125372 |
42 | MP0005451_abnormal_body_composition | 1.53782413 |
43 | MP0009278_abnormal_bone_marrow | 1.52980893 |
44 | MP0003183_abnormal_peptide_metabolism | 1.49377309 |
45 | MP0002998_abnormal_bone_remodeling | 1.47887563 |
46 | MP0000858_altered_metastatic_potential | 1.46884765 |
47 | MP0005166_decreased_susceptibility_to | 1.44858965 |
48 | MP0004947_skin_inflammation | 1.38336367 |
49 | MP0009333_abnormal_splenocyte_physiolog | 1.36008197 |
50 | MP0005310_abnormal_salivary_gland | 1.34147622 |
51 | MP0000689_abnormal_spleen_morphology | 1.31860614 |
52 | MP0002277_abnormal_respiratory_mucosa | 1.29988176 |
53 | MP0002429_abnormal_blood_cell | 1.28139505 |
54 | MP0004883_abnormal_blood_vessel | 1.24686761 |
55 | MP0000465_gastrointestinal_hemorrhage | 1.23515449 |
56 | MP0002722_abnormal_immune_system | 1.17660546 |
57 | MP0008004_abnormal_stomach_pH | 1.14689504 |
58 | MP0003448_altered_tumor_morphology | 1.14619725 |
59 | MP0003690_abnormal_glial_cell | 1.13838094 |
60 | MP0000604_amyloidosis | 1.13120146 |
61 | MP0005167_abnormal_blood-brain_barrier | 1.12221358 |
62 | MP0003866_abnormal_defecation | 1.09777820 |
63 | MP0009840_abnormal_foam_cell | 1.09638473 |
64 | MP0004510_myositis | 1.08888035 |
65 | MP0005164_abnormal_response_to | 1.06244774 |
66 | MP0002132_abnormal_respiratory_system | 1.05841525 |
67 | MP0003763_abnormal_thymus_physiology | 1.03159633 |
68 | MP0002166_altered_tumor_susceptibility | 1.02290858 |
69 | MP0009763_increased_sensitivity_to | 0.97892626 |
70 | MP0003656_abnormal_erythrocyte_physiolo | 0.93926888 |
71 | MP0000920_abnormal_myelination | 0.91170758 |
72 | MP0000015_abnormal_ear_pigmentation | 0.89706033 |
73 | MP0001851_eye_inflammation | 0.81999723 |
74 | MP0005390_skeleton_phenotype | 0.81577404 |
75 | MP0001986_abnormal_taste_sensitivity | 0.78157291 |
76 | MP0001663_abnormal_digestive_system | 0.77979265 |
77 | MP0006054_spinal_hemorrhage | 0.75917231 |
78 | MP0000249_abnormal_blood_vessel | 0.75867822 |
79 | MP0000703_abnormal_thymus_morphology | 0.75446812 |
80 | MP0003795_abnormal_bone_structure | 0.74051019 |
81 | MP0002332_abnormal_exercise_endurance | 0.74014955 |
82 | MP0005075_abnormal_melanosome_morpholog | 0.70205735 |
83 | MP0002396_abnormal_hematopoietic_system | 0.69238723 |
84 | MP0002006_tumorigenesis | 0.68862495 |
85 | MP0009765_abnormal_xenobiotic_induced | 0.67188396 |
86 | MP0004381_abnormal_hair_follicle | 0.64929613 |
87 | MP0001542_abnormal_bone_strength | 0.63298140 |
88 | MP0005174_abnormal_tail_pigmentation | 0.63017911 |
89 | MP0005319_abnormal_enzyme/_coenzyme | 0.62375414 |
90 | MP0001873_stomach_inflammation | 0.58727985 |
91 | MP0000371_diluted_coat_color | 0.58154435 |
92 | MP0008874_decreased_physiological_sensi | 0.54905731 |
93 | MP0005165_increased_susceptibility_to | 0.54183525 |
94 | MP0005367_renal/urinary_system_phenotyp | 0.53632345 |
95 | MP0000516_abnormal_urinary_system | 0.53632345 |
96 | MP0003195_calcinosis | 0.53287563 |
97 | MP0005647_abnormal_sex_gland | 0.51393634 |
98 | MP0003045_fibrosis | 0.51068608 |
99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.46705390 |
100 | MP0002933_joint_inflammation | 0.46676686 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent bacterial skin infections (HP:0005406) | 6.37328464 |
2 | Recurrent abscess formation (HP:0002722) | 6.21276879 |
3 | Abnormality of macrophages (HP:0004311) | 5.67716060 |
4 | Eczematoid dermatitis (HP:0000976) | 5.55207381 |
5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.93043757 |
6 | Myositis (HP:0100614) | 4.79558792 |
7 | Orchitis (HP:0100796) | 4.57508395 |
8 | Retrobulbar optic neuritis (HP:0100654) | 4.53283273 |
9 | Optic neuritis (HP:0100653) | 4.53283273 |
10 | Obstructive lung disease (HP:0006536) | 4.38481672 |
11 | Chronic obstructive pulmonary disease (HP:0006510) | 4.38481672 |
12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.31978672 |
13 | Abnormality of glycolipid metabolism (HP:0010969) | 4.31978672 |
14 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.31978672 |
15 | Stomatitis (HP:0010280) | 4.26354668 |
16 | Mediastinal lymphadenopathy (HP:0100721) | 4.23318130 |
17 | Recurrent skin infections (HP:0001581) | 4.16487599 |
18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.96426998 |
19 | Recurrent fungal infections (HP:0002841) | 3.95772636 |
20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.78784036 |
21 | Recurrent cutaneous fungal infections (HP:0011370) | 3.78784036 |
22 | Meningitis (HP:0001287) | 3.77903085 |
23 | Hemoptysis (HP:0002105) | 3.62341613 |
24 | Increased cerebral lipofuscin (HP:0011813) | 3.50642374 |
25 | Gastrointestinal infarctions (HP:0005244) | 3.50530015 |
26 | Pulmonary infiltrates (HP:0002113) | 3.47425015 |
27 | Urticaria (HP:0001025) | 3.45472101 |
28 | Vasculitis (HP:0002633) | 3.43043319 |
29 | Systemic lupus erythematosus (HP:0002725) | 3.39702913 |
30 | Spontaneous hematomas (HP:0007420) | 3.39088396 |
31 | Amyloidosis (HP:0011034) | 3.37671902 |
32 | Vacuolated lymphocytes (HP:0001922) | 3.37122578 |
33 | Chest pain (HP:0100749) | 3.21226422 |
34 | Keratoconjunctivitis sicca (HP:0001097) | 3.19052903 |
35 | Disinhibition (HP:0000734) | 3.17719507 |
36 | Gingivitis (HP:0000230) | 3.12032052 |
37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.09050580 |
38 | Keratoconjunctivitis (HP:0001096) | 3.01200000 |
39 | Encephalitis (HP:0002383) | 2.95073050 |
40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.88430954 |
41 | Loss of speech (HP:0002371) | 2.85135192 |
42 | Gingival bleeding (HP:0000225) | 2.81470178 |
43 | Dysostosis multiplex (HP:0000943) | 2.81106430 |
44 | Gangrene (HP:0100758) | 2.78106530 |
45 | T lymphocytopenia (HP:0005403) | 2.74160441 |
46 | Arterial thrombosis (HP:0004420) | 2.73829194 |
47 | Pulmonary embolism (HP:0002204) | 2.73028825 |
48 | Petechiae (HP:0000967) | 2.70462220 |
49 | Abnormality of the pleura (HP:0002103) | 2.70135533 |
50 | Epistaxis (HP:0000421) | 2.69751314 |
51 | Abnormality of T cell number (HP:0011839) | 2.68590590 |
52 | Leukocytosis (HP:0001974) | 2.46434595 |
53 | Recurrent viral infections (HP:0004429) | 2.45969228 |
54 | Mutism (HP:0002300) | 2.44229421 |
55 | Abnormality of the prostate (HP:0008775) | 2.44229307 |
56 | Autoimmune thrombocytopenia (HP:0001973) | 2.43862022 |
57 | Polyneuropathy (HP:0001271) | 2.41992703 |
58 | Anorexia (HP:0002039) | 2.41574837 |
59 | Purpura (HP:0000979) | 2.38789539 |
60 | Increased IgM level (HP:0003496) | 2.34558940 |
61 | Episodic fever (HP:0001954) | 2.34196544 |
62 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.34174853 |
63 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.34174853 |
64 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.34174853 |
65 | Pustule (HP:0200039) | 2.34114386 |
66 | Prolonged bleeding time (HP:0003010) | 2.32257793 |
67 | Increased serum ferritin (HP:0003281) | 2.29623262 |
68 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.28878165 |
69 | Osteomyelitis (HP:0002754) | 2.22919182 |
70 | Basal ganglia calcification (HP:0002135) | 2.21524628 |
71 | Cellulitis (HP:0100658) | 2.19110664 |
72 | Premature loss of primary teeth (HP:0006323) | 2.17532668 |
73 | Peritonitis (HP:0002586) | 2.16783657 |
74 | Glomerulopathy (HP:0100820) | 2.16099216 |
75 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.14233895 |
76 | Mucopolysacchariduria (HP:0008155) | 2.14233895 |
77 | Vertigo (HP:0002321) | 2.13508884 |
78 | Inflammation of the large intestine (HP:0002037) | 2.12521967 |
79 | Abnormality of the peritoneum (HP:0002585) | 2.12494391 |
80 | Increased IgE level (HP:0003212) | 2.11752102 |
81 | Amaurosis fugax (HP:0100576) | 2.10503429 |
82 | Abnormality of iron homeostasis (HP:0011031) | 2.09241072 |
83 | Memory impairment (HP:0002354) | 2.07222364 |
84 | Thrombophlebitis (HP:0004418) | 2.06946451 |
85 | Hepatosplenomegaly (HP:0001433) | 2.06625404 |
86 | Abnormality of T cells (HP:0002843) | 2.04050675 |
87 | Agnosia (HP:0010524) | 2.02165219 |
88 | Recurrent pneumonia (HP:0006532) | 1.98537078 |
89 | Panhypogammaglobulinemia (HP:0003139) | 1.97645498 |
90 | Cheilitis (HP:0100825) | 1.97129834 |
91 | Xerostomia (HP:0000217) | 1.95270085 |
92 | Gastrointestinal inflammation (HP:0004386) | 1.95067174 |
93 | Progressive neurologic deterioration (HP:0002344) | 1.94425951 |
94 | Keratitis (HP:0000491) | 1.92191250 |
95 | Skin rash (HP:0000988) | 1.90678153 |
96 | Myocardial infarction (HP:0001658) | 1.86962808 |
97 | Skin ulcer (HP:0200042) | 1.86682925 |
98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86112411 |
99 | Abnormality of the endocardium (HP:0004306) | 1.85339405 |
100 | Abnormality of the pericardium (HP:0001697) | 1.84683706 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.87112977 |
2 | BLK | 4.18500733 |
3 | BMPR2 | 3.52111470 |
4 | TYK2 | 3.13994214 |
5 | MAP4K1 | 2.82712309 |
6 | CSK | 2.67122879 |
7 | IRAK4 | 2.57813403 |
8 | MAP2K3 | 2.39151387 |
9 | CSF1R | 2.39122777 |
10 | FES | 2.34774109 |
11 | TXK | 2.33818347 |
12 | FGR | 2.12278174 |
13 | JAK3 | 2.06482996 |
14 | MAP3K14 | 2.01859664 |
15 | CDK19 | 1.99386518 |
16 | ZAP70 | 1.95747514 |
17 | SYK | 1.89608668 |
18 | LYN | 1.78534865 |
19 | PIK3CG | 1.76879855 |
20 | KIT | 1.72993235 |
21 | MAP3K3 | 1.67478827 |
22 | GRK7 | 1.65777552 |
23 | TAOK3 | 1.62296029 |
24 | BTK | 1.62142493 |
25 | MATK | 1.61872151 |
26 | IKBKB | 1.57443536 |
27 | GRK6 | 1.56813172 |
28 | TNK2 | 1.56627817 |
29 | HCK | 1.56085523 |
30 | TGFBR2 | 1.52141054 |
31 | MAP3K13 | 1.45547397 |
32 | IKBKE | 1.42779674 |
33 | JAK2 | 1.42119940 |
34 | TBK1 | 1.41333720 |
35 | MAP3K12 | 1.38365739 |
36 | JAK1 | 1.36653594 |
37 | ERN1 | 1.30999138 |
38 | LCK | 1.20524798 |
39 | TAOK1 | 1.15445516 |
40 | TEC | 1.14711876 |
41 | IRAK1 | 1.09403005 |
42 | YES1 | 1.07397943 |
43 | MAP3K11 | 1.04860526 |
44 | ITK | 1.04458708 |
45 | IRAK2 | 1.04401632 |
46 | SIK3 | 0.94465763 |
47 | MARK3 | 0.92803809 |
48 | CAMKK2 | 0.89381838 |
49 | MAP3K1 | 0.88500885 |
50 | MAP3K2 | 0.85060641 |
51 | MOS | 0.83975314 |
52 | PDK1 | 0.81252981 |
53 | TAOK2 | 0.77522651 |
54 | IRAK3 | 0.76384345 |
55 | PRPF4B | 0.76169869 |
56 | EPHB1 | 0.72170384 |
57 | KSR2 | 0.66680815 |
58 | PDPK1 | 0.64945793 |
59 | MAP3K5 | 0.64888698 |
60 | ACVR1B | 0.61389781 |
61 | ADRBK2 | 0.59627422 |
62 | DAPK2 | 0.58126565 |
63 | FYN | 0.58104073 |
64 | TESK2 | 0.57710410 |
65 | EGFR | 0.54480235 |
66 | OXSR1 | 0.51498106 |
67 | CDC42BPA | 0.50312551 |
68 | ABL1 | 0.50160346 |
69 | MAP2K6 | 0.49653906 |
70 | TRPM7 | 0.49207446 |
71 | MAP3K6 | 0.47185944 |
72 | PRKCQ | 0.46144869 |
73 | MAPK12 | 0.41596961 |
74 | PTK2B | 0.41264976 |
75 | MAPK7 | 0.41118130 |
76 | STK10 | 0.40845635 |
77 | PIM1 | 0.38808329 |
78 | IGF1R | 0.38711043 |
79 | PRKCD | 0.37881991 |
80 | MAP2K4 | 0.37207973 |
81 | MARK2 | 0.36636342 |
82 | RPS6KC1 | 0.32028654 |
83 | RPS6KL1 | 0.32028654 |
84 | SGK3 | 0.31362836 |
85 | NME2 | 0.31264626 |
86 | DYRK3 | 0.31159385 |
87 | DYRK1B | 0.30646588 |
88 | CHUK | 0.30205959 |
89 | ARAF | 0.29920486 |
90 | RPS6KA6 | 0.29470079 |
91 | SIK2 | 0.27851894 |
92 | ABL2 | 0.27769871 |
93 | STK11 | 0.26841213 |
94 | SGK2 | 0.25374637 |
95 | RAF1 | 0.24775635 |
96 | FRK | 0.24516823 |
97 | ILK | 0.23038464 |
98 | CAMKK1 | 0.22252243 |
99 | KSR1 | 0.21297018 |
100 | PRKG2 | 0.21052117 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Asthma_Homo sapiens_hsa05310 | 4.36078950 |
2 | Allograft rejection_Homo sapiens_hsa05330 | 3.98726206 |
3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.86939767 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.86786378 |
5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.70420885 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 3.40769518 |
7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.17299548 |
8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.09624835 |
9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.70479680 |
10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.56800950 |
11 | Tuberculosis_Homo sapiens_hsa05152 | 2.45740556 |
12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.40947457 |
13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37856489 |
14 | Viral myocarditis_Homo sapiens_hsa05416 | 2.37679251 |
15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.96550789 |
16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94900036 |
17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91722948 |
18 | Phagosome_Homo sapiens_hsa04145 | 1.84671503 |
19 | Legionellosis_Homo sapiens_hsa05134 | 1.74442947 |
20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.72337211 |
21 | Influenza A_Homo sapiens_hsa05164 | 1.60102553 |
22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.46262514 |
23 | Lysosome_Homo sapiens_hsa04142 | 1.45717054 |
24 | Malaria_Homo sapiens_hsa05144 | 1.39932681 |
25 | Pertussis_Homo sapiens_hsa05133 | 1.39472088 |
26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.38003151 |
27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.37172915 |
28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.35884540 |
29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31295787 |
30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.28360410 |
31 | Salmonella infection_Homo sapiens_hsa05132 | 1.26383626 |
32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25032119 |
33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19855895 |
34 | Measles_Homo sapiens_hsa05162 | 1.12161450 |
35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06593885 |
36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.05150324 |
37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02432057 |
38 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98535351 |
39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.98111387 |
40 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.96650660 |
41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96445424 |
42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93365608 |
43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91647101 |
44 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90612342 |
45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.88374910 |
46 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86204414 |
47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85764049 |
48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.84346987 |
49 | Shigellosis_Homo sapiens_hsa05131 | 0.81319785 |
50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79962967 |
51 | Platelet activation_Homo sapiens_hsa04611 | 0.78081293 |
52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65853322 |
53 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65807751 |
54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61827950 |
55 | Hepatitis B_Homo sapiens_hsa05161 | 0.59844154 |
56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57937436 |
57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.57780737 |
58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52784340 |
59 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50101517 |
60 | Hepatitis C_Homo sapiens_hsa05160 | 0.49744407 |
61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48491867 |
62 | Apoptosis_Homo sapiens_hsa04210 | 0.48251997 |
63 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41686199 |
64 | Amoebiasis_Homo sapiens_hsa05146 | 0.37865378 |
65 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37317655 |
66 | Endocytosis_Homo sapiens_hsa04144 | 0.36843120 |
67 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.32756604 |
68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32211770 |
69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31227763 |
70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28761069 |
71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.26314000 |
72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.25969214 |
73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25250437 |
74 | Bladder cancer_Homo sapiens_hsa05219 | 0.24800871 |
75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.23707570 |
76 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.23201915 |
77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22118530 |
78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.20993383 |
79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.19453185 |
80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.19432400 |
81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.19212625 |
82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18150800 |
83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.17845610 |
84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16529211 |
85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.15412587 |
86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14392481 |
87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.13711196 |
88 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.12694717 |
89 | Mineral absorption_Homo sapiens_hsa04978 | 0.12423277 |
90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.11859611 |
91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.11818763 |
92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.09045183 |
93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.08859031 |
94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.08821805 |
95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.06981113 |
96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.05939059 |
97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.05510839 |
98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.04925238 |
99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.04503603 |
100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.04307369 |